• 
  Petar Nikiforov, Sachin Surade, Michal Blaszczyk, Vincent Delorme, Priscille Brodin, et al.. A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. Organic & Biomolecular Chemistry, 2016, 14 (7), pp.2318-2326. ⟨10.1039/c5ob02630j⟩. ⟨hal-04463026⟩
• 
  Borris Galani, Marie-Emmanuelle Sahuc, Frederic Njayou, Gaspard Deloison, Pierre Mkounga, et al.. Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. Frontiers in Microbiology, 2015, 6, pp.488. ⟨10.3389/fmicb.2015.00488⟩. ⟨hal-02104509⟩
• 
  Marion Flipo, Rosangela Frita, Marilyne Bourotte, María Martínez-Martínez, Markus Boesche, et al.. The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis. Science Translational Medicine, 2022, 14 (643), ⟨10.1126/scitranslmed.aaz6280⟩. ⟨hal-04465505⟩
• 
  Florence Levillain, Hongmin Kim, Kee Woong Kwon, Simon Clark, Felipe Cia, et al.. Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. Vaccine, 2020, 38 (6), pp.1416-1423. ⟨10.1016/j.vaccine.2019.11.085⟩. ⟨hal-03014488⟩
• 
  Ghislaine Prevot. Une équipe de recherche en santé : TBIP : Faites connaissance avec l'équipe de recherche en santé : Biome tropical & Immuno-Physiopathologie. Lemag', 2021, n°4, pp.29-33. ⟨hal-04560840⟩

863

578